White label ELPA - ClinicalTrials.eu

Study on Hydroxychloroquine for Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies

Recruiting

3 1 1
Investigated drugs:
- Hydroxychloroquine Sulfate
Study on Avoiding Anticoagulation with Apixaban for Patients with Intracerebral Hemorrhage

Recruiting

3 1 1 1
Investigated diseases:
- Cerebral haemorrhage
Investigated drugs:
- Apixaban
Comparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer

Recruiting

4 1 1 1
Investigated diseases:
- HER2 positive breast cancer
Investigated drugs:
+5
A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

Recruiting

3 1 1
Investigated drugs:
- Humanised Igg1 Kappa Fragment Antibody Targeting Tfr1 Conjugated To P125 Oligonucleotide
- Sodium Chloride Ph. Eur.
+1
A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

Recruiting

3 1 1
Investigated drugs:
- Belzutifan
- Lenvatinib
+4
A study to evaluate the use of [68Ga]BED003 for imaging colorectal, gastric, pancreatic, breast, and ovarian cancers.

Recruiting

2 1 1
Investigated diseases:
A study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome

Recruiting

3 1
Investigated diseases:
- Lennox-Gastaut syndrome
Investigated drugs:
- Clemizole Hydrochloride
A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Recruiting

3 1 1 1
Investigated diseases:
- Ovarian cancer
Investigated drugs:
- Bevacizumab
- Sacituzumab Tirumotecan
+9
A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn’s disease

Recruiting

3 1 1 1
Investigated diseases:
- Colitis ulcerative
- Crohn’s disease
Investigated drugs:
- Mirikizumab
A study of daraxonrasib (RMC-6236) compared to observation in patients with resected pancreatic cancer following chemotherapy

Recruiting

3 1 1
Investigated diseases:
- Ductal adenocarcinoma of pancreas
Investigated drugs:
- (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies